DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
1404
BETFISOLIMAB
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
BETFISOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EXLINKIBART
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
EXLINKIBART
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-522
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MEDI-522
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAMATATUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
SAMATATUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PRADUSINSTOBART
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
PRADUSINSTOBART
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACRIXOLIMAB
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
ACRIXOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PRO-542
2
Antibody
Investigational
Unknown
Unknown
HIV Infections; Acquired Immunodeficiency Syndrome
Envelope glycoprotein gp160 inhibitor
PRO-542
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
F16SIP 131I
2
Antibody
Investigational
Unknown
Unknown
Neoplasms
Tenascin binding agent
F16SIP 131I
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OPICINUMAB
2
Antibody
Investigational
Unknown
Unknown
Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Optic Neuritis
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 inhibitor
OPICINUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
WX1WTN0Y15
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEROPAVIMAB
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
TEROPAVIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALPITATUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
ALPITATUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLACULUMAB
2
Antibody
Investigational
Unknown
Unknown
Sciatica; Arthritis, Rheumatoid
TNF-alpha inhibitor
PLACULUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
S80W9W569L
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LICAMINLIMAB
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
LICAMINLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BECOTATUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
BECOTATUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HBM9161
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
HBM9161
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOVECIMIG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
TOVECIMIG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALDASTOTUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
ALDASTOTUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CILETATUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
CILETATUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLUTAVIMAB
2
Antibody
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
PLUTAVIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DALMITAMIG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
DALMITAMIG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PACMILIMAB
2
Antibody
Investigational
Unknown
Unknown
Lymphoma; Breast Neoplasms; Melanoma
Programmed cell death 1 ligand 1 binding agent
PACMILIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
ZXP96ZI2RA
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HUHMFG1
2
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms
Mucin-1 other
HUHMFG1
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETOKIMAB
2
Antibody
Investigational
Unknown
Unknown
Asthma; Dermatitis, Atopic; Peanut Hypersensitivity; Sinusitis
Interleukin-33 binding agent
ETOKIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
7UWT6B0L2U
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HU14.18-IL2
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
HU14.18-IL2
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VISILIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Lymphoma; Colitis, Ulcerative; Crohn Disease; Graft vs Host Disease; Leukemia, Myeloid, Acute
T-cell surface glycoprotein CD3 epsilon chain inhibitor
VISILIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
H18SKU3289
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLZASTOBART
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
POLZASTOBART
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MM-121
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Breast Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Receptor tyrosine-protein kinase erbB-3 antagonist
MM-121
×
Maximum Phase:
2
First Approval:
None
UNII:
1N3L70MDFX
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PAMLECTABART TISMANITIN
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
PAMLECTABART TISMANITIN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IERAMILIMAB
2
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Melanoma; Triple Negative Breast Neoplasms
Lymphocyte activation gene 3 protein inhibitor
IERAMILIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
OI8P0SFD4R
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEMARITUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Adenocarcinoma
Unknown
BEMARITUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
RJW23BQ0KW
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAB-425
2
Antibody
Investigational
Unknown
Unknown
Glioma
Epidermal growth factor receptor erbB1 inhibitor
MAB-425
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENOKIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Asthma
Interleukin-9 inhibitor
ENOKIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
I4BE5F78HR
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBEROTATUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
OBEROTATUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VIBOSTOLIMAB
2
Antibody
Investigational
Unknown
Unknown
Melanoma; Neoplasms; Prostatic Neoplasms, Castration-Resistant; Carcinoma, Non-Small-Cell Lung
T-cell immunoreceptor with Ig and ITIM domains antagonist
VIBOSTOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
5XO3JF0FEK
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IZENIVETMAB
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
IZENIVETMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
17
18
19
20
21
22
23
…
40
41
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA